Global Anti-malarial Drugs Market Overview:
Global Anti-malarial Drugs Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global Anti-malarial Drugs Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Anti-malarial Drugs involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Anti-malarial Drugs Market:
The Anti-malarial Drugs Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Anti-malarial Drugs Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Anti-malarial Drugs Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Anti-malarial Drugs market has been segmented into:
Aminoquinolines
Quinoline-methanol (4-quinolinemethanols
By Application, Anti-malarial Drugs market has been segmented into:
Oral and Injectable
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Anti-malarial Drugs market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Anti-malarial Drugs market.
Top Key Players Covered in Anti-malarial Drugs market are:
Major players operating in the global anti-malarial drugs market include Ipca Laboratories Ltd.
Zydus Group
Merck KGaA
Pfizer Inc.
GSK plc.
Cipla Inc.
Sun Pharmaceutical Industries Ltd.
Novartis AG
Alvizia Health Care
Bayer AG
F. Hoffmann-La Roche Ltd.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Anti-malarial Drugs Market by Type
4.1 Anti-malarial Drugs Market Snapshot and Growth Engine
4.2 Anti-malarial Drugs Market Overview
4.3 Aminoquinolines
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Aminoquinolines: Geographic Segmentation Analysis
4.4 Quinoline-methanol (4-quinolinemethanols
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Quinoline-methanol (4-quinolinemethanols: Geographic Segmentation Analysis
Chapter 5: Anti-malarial Drugs Market by Application
5.1 Anti-malarial Drugs Market Snapshot and Growth Engine
5.2 Anti-malarial Drugs Market Overview
5.3 Oral and Injectable
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Oral and Injectable: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Anti-malarial Drugs Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MAJOR PLAYERS OPERATING IN THE GLOBAL ANTI-MALARIAL DRUGS MARKET INCLUDE IPCA LABORATORIES LTD.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 ZYDUS GROUP
6.4 MERCK KGAA
6.5 PFIZER INC.
6.6 GSK PLC.
6.7 CIPLA INC.
6.8 SUN PHARMACEUTICAL INDUSTRIES LTD.
6.9 NOVARTIS AG
6.10 ALVIZIA HEALTH CARE
6.11 BAYER AG
6.12 AND F. HOFFMANN-LA ROCHE LTD.
Chapter 7: Global Anti-malarial Drugs Market By Region
7.1 Overview
7.2. North America Anti-malarial Drugs Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Aminoquinolines
7.2.4.2 Quinoline-methanol (4-quinolinemethanols
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Oral and Injectable
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Anti-malarial Drugs Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Aminoquinolines
7.3.4.2 Quinoline-methanol (4-quinolinemethanols
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Oral and Injectable
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Anti-malarial Drugs Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Aminoquinolines
7.4.4.2 Quinoline-methanol (4-quinolinemethanols
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Oral and Injectable
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Anti-malarial Drugs Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Aminoquinolines
7.5.4.2 Quinoline-methanol (4-quinolinemethanols
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Oral and Injectable
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Anti-malarial Drugs Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Aminoquinolines
7.6.4.2 Quinoline-methanol (4-quinolinemethanols
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Oral and Injectable
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Anti-malarial Drugs Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Aminoquinolines
7.7.4.2 Quinoline-methanol (4-quinolinemethanols
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Oral and Injectable
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Anti-malarial Drugs Scope:
|
Report Data
|
Anti-malarial Drugs Market
|
|
Anti-malarial Drugs Market Size in 2025
|
USD XX million
|
|
Anti-malarial Drugs CAGR 2025 - 2032
|
XX%
|
|
Anti-malarial Drugs Base Year
|
2024
|
|
Anti-malarial Drugs Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Major players operating in the global anti-malarial drugs market include Ipca Laboratories Ltd., Zydus Group, Merck KGaA, Pfizer Inc., GSK plc., Cipla Inc., Sun Pharmaceutical Industries Ltd., Novartis AG, Alvizia Health Care, Bayer AG, and F. Hoffmann-La Roche Ltd..
|
|
Key Segments
|
By Type
Aminoquinolines
Quinoline-methanol (4-quinolinemethanols
By Applications
Oral and Injectable
|
